Literature DB >> 10977418

Barriers to using cost-effectiveness analysis in managed care decision making.

L A Prosser1, J P Koplan, P J Neumann, M C Weinstein.   

Abstract

Managed care organizations would appear to be natural advocates for, and users of, cost-effectiveness analysis (CEA) as a tool for maximizing health outcomes for their covered populations within fixed budgets. There is, however, little evidence that CEA plays a major role in managed care decision making. The purpose of this paper is to identify barriers to both conducting and using CEA in managed care decision making. Lack of understanding about the value and applicability of CEA, and incentives that do not align with a lifetime perspective on either health outcomes or costs may be at least as important as perceived or real methodological limitations of the methodology. Research focused on ways to overcome these barriers, and thereby improve resource allocations, is recommended.

Mesh:

Year:  2000        PMID: 10977418

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  7 in total

1.  Cost effectiveness analysis in health care: contraindications.

Authors:  Cam Donaldson; Gillian Currie; Craig Mitton
Journal:  BMJ       Date:  2002-10-19

2.  Helping smokers quit: understanding the barriers to utilization of smoking cessation services.

Authors:  Sarah E Gollust; Steven A Schroeder; Kenneth E Warner
Journal:  Milbank Q       Date:  2008-12       Impact factor: 4.911

3.  Do changes in drug coverage policy point to an increased role for cost-effectiveness analysis in the USA?

Authors:  James D Chambers
Journal:  Pharmacoeconomics       Date:  2014-08       Impact factor: 4.981

4.  Should physicians be gatekeepers of medical resources?

Authors:  M C Weinstein
Journal:  J Med Ethics       Date:  2001-08       Impact factor: 2.903

Review 5.  Economic evaluation of drug abuse treatment and HIV prevention programs in pregnant women: a systematic review.

Authors:  Jennifer Prah Ruger; Christina M Lazar
Journal:  Addict Behav       Date:  2011-08-05       Impact factor: 3.913

6.  Time to incorporate time in cost-effectiveness analysis.

Authors:  Gijs van de Wetering; Willem H Woertman; Eddy M Adang
Journal:  Eur J Health Econ       Date:  2012-06

7.  The role of economics in the QUERI program: QUERI Series.

Authors:  Mark W Smith; Paul G Barnett
Journal:  Implement Sci       Date:  2008-04-22       Impact factor: 7.327

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.